Sartorius | SRT3 - Current Liabilities

Stock Price
217.10
Daily Change
2.20 1.02%
Monthly
0.74%
Yearly
-3.12%
Q2 Forecast
232.54

Sartorius reported EUR2.11B in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Akebia Therapeutics USD 162.94M 29.56M Dec/2025
Alaunos Therapeutics USD 921K 153K Sep/2025
Avita Medical AUD 62.68M 77K Dec/2025
Dianthus Therapeutics USD 30.73M 6.88M Dec/2025
Ionis Pharmaceuticals USD 783M 120.46M Dec/2025
IQVIA Holdings USD 8.34B 170M Dec/2025
Moderna USD 1.99B 306M Dec/2025
Organon & Co USD 2.68B 117M Sep/2025
Revvity USD 1.33B 108.5M Dec/2025
Sartorius EUR 2.11B 145.8M Mar/2026
Tectonic Therapeutic USD 9.67M 293K Dec/2025
Viatris USD 7.09B 269.8M Dec/2025
Xeris Pharmaceuticals USD 109.57M 6.63M Dec/2025